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Abstract
Background: Perioperative blood transfusion carries numerous potential risks concerning the
transmission of infective diseases and immunodepression that can facilitate the occurrence of
postoperative infectious complications. Explanation of connections between perioperative blood
transfusion and postoperative septic complication worldwide is not well documented. Many studies
have described a correlation between perioperative blood transfusions and postoperative
infections. On the contrary, other studies indicate that factors influencing the need for blood
transfusions during surgery have a greater bearing than blood transfusion per se on the occurrence
of postoperative complications.
Patients and methods: A prospective study was conducted in our Department on 110
consecutive patients undergoing oesophageal resection for primary cancer, in order to evaluate the
incidence of postoperative infections related to perioperative allogenic blood transfusions. For
each patient we preoperatively recorded in a computerized data-base several known risk-factors
for postoperative infections; in detail we registered the administration of allogenic perioperative
blood transfusions (period of administration, number of packages administered).
Results: Among the enrolled 110 patients, 53 (48%) received perioperative blood transfusions: in
this group postoperative infections (overall infective complications) occurred in 27 patients. After
a multivariate analysis we observed that perioperative blood transfusions significantly affected as an
independent variable the development of wound infections (p = 0.02).
Conclusion: Blood transfusions independently affected the incidence of wound infections in
patients who underwent oesophageal resection for primary cancer.
Background
Nosocomial infections are the most frequent complica-
tions observed in surgical oncological patients; despite
considerable progress in the areas of prevention, diagno-
sis and therapy, postoperative infections continue to be
associated with significant morbidity, sometimes with
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ics, blood derivatives, nursing, additional surgical proce-
dures and prolonged hospitalization [1-3].
Most surgical infections are acquired intraoperatively and
are endogenous, arising from the flora of the patient's
skin, gastrointestinal tract or mucous membranes. Exoge-
nous infections are less common and are probably
acquired from the skin or nasal flora of the operating
team, or more rarely from contaminated material or
instruments in the operating theatre.
The risk of postoperative surgical infections is mainly
related to the magnitude of surgical field contamination.
The opening of the lumen of the organ containing bacte-
ria always involves a relevant risk for postoperative
wound infections. In 1964, Altemeier and the National
Research Council [4] proposed a classification of surgical
procedures related to the degree of bacterial contamina-
tion. This wound classification scheme has served as the
basis for recommending antibiotic use, for preoperative
bowel preparation, for directing wound management and
for focusing wound surveillance.
Surveillance studies using classification of surgical proce-
dures related to operative field contamination showed
large variations in postoperative infection rates among
different Centres, for the same type of procedures. These
discrepancies led to the identification of other risk factors
that might significantly influence the occurrence of infec-
tious complications. It is through the control of such fac-
tors that better clinical results may be achieved.
These other factors affecting the incidence of postopera-
tive infections have been identified through clinical and
experimental studies carried out during the last decades;
these may be divided into two groups: treatment-related
and patient-related. The first group includes quality of sur-
gical care, type and duration of surgery, emergency proce-
dure, immunosuppressive therapy, blood transfusions.
The second group comprises advanced age, co-morbidity,
pre-existing infections, malnutrition and host defence
deficiency.
Perioperative blood transfusion carries numerous poten-
tial risks concerning the transmission of infective diseases
and immunodepression that can facilitate the occurrence
of postoperative infectious complications. Explanation of
relation between perioperative blood transfusion and
postoperative septic complication is not well docu-
mented.
Many studies have described a correlation between peri-
operative blood transfusions and postoperative infections
[5-10], suggesting that blood transfusion interferes with
the immune system of the recipient; thus transfusion-
related immunomodulation may have an impact on host
defence and on the clinical course of patients who
received blood components. Firstly, the immunosuppres-
sive effects of allogeneic blood were noticed in 1973,
when it was shown that renal transplant survival was
improved in a group who received blood transfusions.
Since then, several clinical studies, comparing groups of
patients which needed perioperative blood transfusions
with non-transfused patients, were carried out to evaluate
the real immunosuppressive mechanism and its relation-
ship with postoperative infectious complications. Moreo-
ver, studies evaluating the correlation between the
amount of transfused blood units with infective complica-
tions demonstrated dose-related effect [11,12].
On the other hand, other studies indicate that factors
influencing the need for blood transfusions during sur-
gery have a greater bearing than blood transfusion per se
on the occurrence of postoperative complications [13,14].
In fact, those clinical studies underlying the relationship
between blood transfusion and postoperative infective
complications have difficulties in being adjusted for the
effects of many confounding variables related to the sever-
ity of illness, the various risk-factors for infections at spe-
cific sites and the surgical procedure.
Nevertheless, a meta-analysis recently published and
some larger observational studies, in which Authors tried
to make adjustments for many potentially confounding
variables, came to the conclusion that this correlation
exists [15-17].
Prospective studies investigating the association between
blood transfusions and postoperative infections are
needed, to justify more accurately the indications for
blood transfusions.
Aims of the study
A prospective study was conducted in our Department of
Surgical Sciences of University of Insubria in Varese,
between August 1987 and January 2005, on 110 consecu-
tive patients undergoing oesophageal resection for pri-
mary cancer. The purposes of this prospective study were
to set up a data bank on surgical infections observed, in
order to systematically register such infections complica-
tions; to observe the incidence of postoperative infections
related to perioperative blood transfusions.
Patients and methods
We prospectively studied 110 consecutive patients admit-
ted to our Institute and undergoing resection for oesopha-
geal cancer performed by the same surgical team. The
average age was 62 ± 9 years (range 38–80); 92 were male
and 18 female.Page 2 of 6
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terized data-base the following risk-factors: diabetes, ster-
oid therapy, obesity, chronic renal failure, cirrhosis, pre-
existing chronic pulmonary disease, neoadjuvant radio-
chemotherapy, nutritional and immunological parame-
ters such as serum albumin and lymphocyte count.
Postoperatively, we prospectively monitored patients
daily recording the development of infective complica-
tions such as pneumonia, wound infection, urinary tract
infection, as well as septic complications and the presence
of abdominal abscess and anastomotic leakage.
The type of operation, the duration of surgery, the preop-
erative hospitalization, the need of antibiotic therapy, the
postoperative hospital stay were also registered. A careful
monitoring and registration of perioperative blood trans-
fusions (number of units and period of administration)
was done.
According to the classification proposed by Altemeier and
the National Research Council, in the absence of pre-exist-
ing thoracic or abdominal infection and if the surgical
procedure is carried out with skilled technique, the
oesophageal resection is considered a clean-contaminated
procedure, because there is a surgical opening of the
oesophagus and subsequent anastomosis, with controlled
contamination of the surgical field.
Analysis of results and statistical methods
The significance of any difference in the characteristics of
the oesophageal cancer patients was evaluated. Where dif-
ferences were found Cox's proportional hazard regression
(univariate and multivariate analysis) was used to identify
independent predictors of postoperative infections.
Data were expressed as mean with standard deviation or
median and range according to the data distribution. Stu-
dent's t test was used for analysis of continuous data and
the chi-square test was used to compare differences
between proportions. Mann-Whitney U Test was used to
compare median values. P-values < 0.05 were considered
significant. Statistical package for social sciences (SPSS
version 11.0, MapInfo Corporation, Troy, NY, USA) was
used for data analysis.
Results
After resection of the oesophageal cancer, surgical recon-
struction was obtained by oesphago-gastric stapled anas-
tomosis in 107 patients (97%; 20 cervical and 87
thoracic), oesophago-digiunal anastomosis in 2 patients
and an anastomosis with pharynx in 1 patient.
Out of 110 patients, 12 (11%) had wound infections, 19
(17%) pulmonary infections; 10 (9%) urinary tract infec-
tions; 15 (14%) intra abdominal abscess and anastomotic
leakage. The perioperative mortality was 2.7% (3
patients). Table 1 shows biochemical data related to the
development of surgical infections.
Among the enrolled 110 patients, 53 (48%) received peri-
operative blood transfusions, with an average number of
blood units transfused per patient of 1.5 ± 2 (range 1–12).
In all these patients blood transfusions were administered
perioperatively (intraoperatively or in the first 48 hours
from surgical procedure). In the transfused group postop-
erative infections (overall infective complications)
occurred in 27 (51%) compared to 20 (35%) of infections
registered in 57 non-transfused patients. In a univariate
analysis this difference did not reach a statistical signifi-
cance: p = 0.093 (Table 2).
After a multivariate analysis we observed that periopera-
tive blood transfusions was an independent variable for
the development of wound infections (p = 0.02), while
the development of postoperative infection, pulmonary
infections, urinary tract infections and anastomotic dehis-
cence with abscess were not significantly influenced by
blood transfusions as independent factor (p-value 0.11;
0.93; 0.13 and 0.82 respectively). The microorganisms fre-
quently isolated from different cultural samples are
detailed in tables 3, 4 and 5.
Discussion
In the last decade the immunosuppressive effect of blood
transfusion has been studied in detail.
Table 1: Association between continuous variables and postoperative infections
Patients who developed infections (N = 47) 
(Mean ± SD)
Patients who did not develop infections (N = 63) 
(Mean ± SD)
p-value
Haemoglobin (g/dl) 13.5 ± 2 13.5 ± 2 NS
Haematocrit (%) 39.8 ± 4.8 40.6 ± 5.6 NS
Serum albumin (g/dl) 3.9 ± 0.4 3.9 ± 0.7 NS
Blood lymphocytes level/mm3 1766 ± 764 1869 ± 790 NS
Preoperative hospital stay (days) 15.8 ± 12.6 12 ± 7 0.057
Postoperative hospital stay (days) 15.8 ± 12.6 17.9 ± 12.7 NS
Length of operation (min) 300 ± 87 276 ± 99 NSPage 3 of 6
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underwent major surgical procedures received blood
transfusions, several studies were carried out to investigate
whether homologous blood transfusions significantly
affect postoperative septic morbidity and mortality [18].
Clinical effects of transfusion-induced immunosuppres-
sion in surgical patients have been largely debated in the
literature with contradictory results.
The immunosuppressive effect is supported when consid-
ering the lower degree of allogeneic transplant rejection
and a higher frequency of cancer recurrence in patients
who underwent blood transfusions [19].
Historically, Opelz and Terasaki demonstrated that blood
transfusions before surgery of kidney transplant may pro-
long graft survival. Likewise, it was noticed that blood
transfusions seemed to prevent recurrent abortions and
led to lower recurrence rates in Crohn's disease and, now-
adays, several studies support the hypothesis that alloge-
neic blood transfusion is an independent risk-factor for
the development of postoperative bacterial infection
[20,21]. Transfusion-induced immunosuppression is
thought to mediate this effect [22,23].
Three mechanisms are mainly involved in blood transfu-
sions associated with infections: 1) direct transmission of
the infection from donor to recipient through blood
micro-organisms; 2) activation of pre-existant or latent
recipient infection; and 3) activation of recipient immu-
nity defence.
Immunological alterations following blood transfusion
can produce a clinical effect.
Blood transfusion may interfere with the immunological
response interacting with macrophages and with lym-
phocytes. These cells play a primary role in wound and
anastomotic healing in the postoperative period, and raise
the incidence of peri-anastomotic abscess and generalized
peritonitis [24,25].
In fact it is documented that blood transfusions may delay
wound and anastomotic healing by interfering with the
specific actions of these cells. Moreover, blood transfu-
sions in patients who underwent nephrodyalisis blocked
the lymphocytic response toward different mitogenic and
antigenic molecules; suppressor lymphocytes were
enhanced and an inverted ratio between T-helper and T-
suppressor lymphocytes was observed [26].
Prolonged T- lymphocytes suppression after blood trans-
fusion in patients with chronic inflammatory bowel dis-
ease was reported [27]. Lymphocytic response to
phitohaemo-agglutinin, concavalin A and such antigen
was seen for a period of 4 weeks following blood transfu-
sion in abdominal and thoracic surgery.
Blood transfusion has also been identified as a high risk-
factor of complications in emergency surgery for bowel
perforation related to abdominal blunt trauma [5]. The
direct relationship between the number of blood units
transfused and better survival was also documented [28-
30].
Table 3: More frequent microorganisms isolated from infected 
wound
Type of microorganism # patients
Escherichia coli 8
Staphylococcus aureus 6
Pseudomonas aeruginosa 3
Enterococcus faecium 2
Staphylococcus epidermidis 2
Enterococcus faecalis 1
Table 2: Incidence of postoperative infections in transfused and non transfused patients (univariate analysis)
Patients who received transfusions (n = 53) Patients who did not receive transfusions (n = 57) p-value
# patients with a postoperative infection 27 20 0.093
Wound infections 8 4 0.175
Respiratory infections 10 9 0.670
Urinary tract infections 9 1 0.005
Abscess/anastomotic leakage 9 6 0.324
Table 4: More frequent microorganisms isolated from sputum in 
patients with respiratory infections
Type of microorganism # patients
Pseudomonas aeruginosa 12
Staphylococcus aureus 9
Candida species 5
Escherichia coli 3
Enterobacter cloacae 2
Stenotrophomonas maltophilia 2
Staphylococcus epidermidis 1
Haemophilus influenzae 1
Enterococcus faecalis 1Page 4 of 6
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Several Authors documented that the immunosuppressive
effect of blood transfusion is greater when it is given intra-
operatively or in the immediate postoperative period
(within the first 48–72 hours from surgical procedure).
Bellantone et al., reported a likely association between
postoperative infections and postoperative transfusion
[31].
Despite the above mentioned clinical studies seem to cor-
relate blood transfusion as an independent risk-factor to
postoperative complications, a causal relationship
between blood transfusion and an increase in the risk of
postoperative infection is hard to prove in the clinical set-
ting, firstly because obviously these are not randomized
studies and secondly for the doubtful role of too many
confounding variables. It is based on these considerations
that some authors proposed that the detection of a rela-
tionship between postoperative infections and periopera-
tive blood transfusions may depend on many patient and
surgical variables that may complicate interpretation of
the results; indeed, it remains to be elucidated whether
blood transfusion is an independent variable causing sur-
gical infections, or it is a variable dependant on other
more important risk-factors (i.e. anemia) [13].
After a careful multivariate analysis we observed a higher
number of postoperative wound infections in patients
that received perioperative blood transfusions compared
with patients that did not (p = 0.02). Eight out of twelve
patents (67%) who developed this kind of postoperative
complication received blood transfusions. Blood transfu-
sions independently affected the incidence of wound
infections in patients who underwent oesophageal resec-
tion for primary cancer.
Conclusion
The results of our study are similar to those obtained by
other studies that came to the same conclusions we sup-
port a cautious interpretation of the effects of periopera-
tive blood transfusions on postoperative infective
complications. The blood transfusion may induce immu-
nomodulation and consequently immunodepression so
whenever possible perioperative blood transfusion has to
be limited.
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